EUVIMEDEUVIMED entdecken
Open Access

CEBPB-Regulated Gastric Cell Plasticity Promotes Liver Metastasis of Gastric Cancer

Zhixiang Zuo, Jiaqi Liang, Li-Na He, Kai Xu, Muren Hu, Kunming Zhang, Wei Gao, Junyi Yin, Lanlin Zhang, Boning Ma, Zhiqian Hu, Pengfei Zhang und 1 weitere

Cancer Communications · 01.01.2026 · 46

DOI: 10.34133/cancomm.0016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Communications, online erschienen am 12.03.2026. Verfasst von Zhixiang Zuo und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, School of Life Sciences, Sun Yat…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Liver Neoplasms, CCAAT-Enhancer-Binding Protein-beta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shenzhen Medical Research Fund, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver metastasis represents the most common distant dissemination in gastric cancer (GC) but persists as a challenging condition to manage, and its driving molecular mechanisms remain poorly understood. This study aimed to uncover the key regulatory drivers of GC liver metastasis and explore their potential as therapeutic targets.

Methods

Herein, we employed a multifaceted approach combining single-cell RNA sequencing, bulk transcriptomics, epigenomics analyses of GC primary tumors and normal adjacent tissues, paired liver metastasis, and circulating tumor cells, alongside in vitro and in vivo experimental validation, to investigate how metastatic GC cells spread to and adapt within the liver microenvironment.

Results

We discovered that GC cells undergoing liver metastasis transcriptionally reprogrammed into a high plasticity state. This plasticity was mediated by the transcription factor CCAAT enhancer-binding protein beta ( CEBPB ), which activated liver metastasis-associated genes through enhancer reprogramming. Notably, CEBPB -driven reprogramming enhanced the metastatic potential of GC cells and enabled them to evade immune surveillance via interactions between cluster of differentiation 155 (CD155) and T cell immunoreceptor with Ig and ITIM domains (TIGIT). Blocking the CD155–TIGIT interplay inhibited liver metastasis and restored T cell cytotoxicity.

Conclusions

Our study identifies CEBPB-mediated transcriptional and epigenetic reprogramming as a fundamental driver of GC liver metastasis. Our findings underscore the CEBPB / CD155 / TIGIT axis as a promising therapeutic target for liver-metastatic GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsLiver NeoplasmsCCAAT-Enhancer-Binding Protein-betaHumansAnimalsMiceCell Line, TumorGene Expression Regulation, NeoplasticTumor MicroenvironmentFemale

Substanzen

CCAAT-Enhancer-Binding Protein-betaCEBPB protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, School of Life Sciences, Sun Yat-sen University, Guangzhou 510060, Guangdong, P. R. China.
  • Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510300, Guangdong, P. R. China.
  • Department of General Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200092, P. R. China.
  • Department of Gastrointestinal Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, P. R. China.
  • Department of Oncology, The First Affiliated Hospital, Jinan University, Guangzhou 510630, Guangdong, P. R. China.
  • Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, P. R. China.

Förderung

  • Shenzhen Medical Research Fund
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Research Project of Shanghai Municipal Commission of Health and Family Planning

Zitieren

APA

Zuo, Z., Liang, J., He, L. N., Xu, K., Hu, M., Zhang, K., Gao, W., Yin, J., Zhang, L., Ma, B., Hu, Z., Zhang, P., & Jiang, H. (2026). CEBPB-Regulated Gastric Cell Plasticity Promotes Liver Metastasis of Gastric Cancer. Cancer Communications, 46. https://doi.org/10.34133/cancomm.0016

Vancouver

Zuo Z, Liang J, He LN, Xu K, Hu M, Zhang K, et al. CEBPB-Regulated Gastric Cell Plasticity Promotes Liver Metastasis of Gastric Cancer. Cancer Communications. 2026;46. doi:10.34133/cancomm.0016

BibTeX
@article{Zuo2026,
  author = {Zuo, Zhixiang and Liang, Jiaqi and He, Li-Na and Xu, Kai and Hu, Muren and Zhang, Kunming and Gao, Wei and Yin, Junyi and Zhang, Lanlin and Ma, Boning and Hu, Zhiqian and Zhang, Pengfei and Jiang, Hong},
  title = {CEBPB-Regulated Gastric Cell Plasticity Promotes Liver Metastasis of Gastric Cancer},
  journal = {Cancer Communications},
  year = {2026},
  volume = {46},
  doi = {10.34133/cancomm.0016}
}
Kostenlos starten →